Alx Oncology Holdings (ALXO) Net Equity Issued and Repurchased (2019 - 2026)
Alx Oncology Holdings (ALXO) recorded Net Equity Issued and Repurchased of $73,000 in Q2 2026, down 89.1% from the prior quarter.
Alx Oncology Holdings (ALXO) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
On a TTM basis, Alx Oncology Holdings' Net Equity Issued and Repurchased came in at $2.06 million as of Jun 30, 2026, up 155.5% year-over-year; for FY2025, it was $1.69 million, down 94.3% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -65.9% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $29.66 million in FY2024, $523,000 in FY2023 (-7.8%), $567,000 in FY2022 (-77.8%) and $2.55 million in FY2021 (-99.3%).
- The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased since Q3 2022.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in three of the last four quarters, with growth averaging 88.3%.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 266.6% in Q4 2025, against a decline of 99.7% in Q4 2021 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alx Oncology Holdings | 168.62 Mn | 168.62 Mn | - | 73,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73,000.00 |
| Mar 31, 2026 | 670,000.00 |
| Dec 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 372,000.00 |
| Dec 31, 2024 | 359,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 185,000.00 |
| Dec 31, 2022 | 222,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 155,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Dec 31, 2021 | 529,000.00 |
| Sep 30, 2021 | 543,000.00 |
| Jun 30, 2021 | 701,000.00 |
| Mar 31, 2021 | 778,000.00 |
| Dec 31, 2020 | 195.53 Mn |
| Sep 30, 2020 | 68.04 Mn |
| Jun 30, 2020 | -311,000.00 |
Alx Oncology Holdings Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALXO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();